The proto-oncogene Mer tyrosine kinase is a novel therapeutic target in mantle cell lymphoma. [electronic resource]
- Journal of hematology & oncology 03 2018
- 43 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1756-8722
10.1186/s13045-018-0584-6 doi
Animals Female Humans Lymphoma, Mantle-Cell--drug therapy Mice Mice, Inbred NOD Mice, SCID Protein Kinase Inhibitors--pharmacology Proto-Oncogene Mas Survival Analysis